Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan G Kermode

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 26, 2015
Rapid exacerbation of neuromyelitis optica after rituximab treatmentYongqiang Dai, Tingting Lu, Yuge Wang, et al.
Journal of Neurology|March 8, 2005
Corticomotor organisation and motor function in multiple sclerosisGary W Thickbroom, Michelle L Byrnes, Sarah A Archer, et al.
Journal of the Neurological Sciences|January 9, 2010
Wedge-shaped medullary lesions in multiple sclerosisWei Qiu, Sonja Raven, Jing-Shan Wu, et al.
Multiple Sclerosis and Related Disorders|April 6, 2018
B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorderTingting Lu, Yaqing Shu, Yongqiang Dai, et al.
Brain Sciences|June 28, 2023
Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing-Remitting Multiple Sclerosis: A Retrospective Cohort StudyXingwei Fang, Yaxin Lu, Yongmei Fu, et al.
BMJ Open|June 9, 2022
Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: a systematic review and network meta-analysis protocolJulia Lyons, Stephanie Campese, Yvonne C Learmonth, et al.
Multiple Sclerosis and Related Disorders|July 20, 2024
Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: A systematic reviewStephanie Campese, Julia Lyons, Yvonne C Learmonth, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 26, 2017
Infections in neuromyelitis optica spectrum disorderXiaonan Zhong, Yifan Zhou, Tingting Lu, et al.
Frontiers in Immunology|January 28, 2021
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple SclerosisStephanie Trend, Jonatan Leffler, Ingrid Teige, et al.
Multiple Sclerosis and Related Disorders|October 11, 2025
Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosisPrue H Hart, Christopher J Emig, Ahmed Z Obeidat, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 26, 2015
Rapid exacerbation of neuromyelitis optica after rituximab treatmentYongqiang Dai, Tingting Lu, Yuge Wang, et al.
Journal of Neurology|March 8, 2005
Corticomotor organisation and motor function in multiple sclerosisGary W Thickbroom, Michelle L Byrnes, Sarah A Archer, et al.
Journal of the Neurological Sciences|January 9, 2010
Wedge-shaped medullary lesions in multiple sclerosisWei Qiu, Sonja Raven, Jing-Shan Wu, et al.
Multiple Sclerosis and Related Disorders|April 6, 2018
B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorderTingting Lu, Yaqing Shu, Yongqiang Dai, et al.
Brain Sciences|June 28, 2023
Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing-Remitting Multiple Sclerosis: A Retrospective Cohort StudyXingwei Fang, Yaxin Lu, Yongmei Fu, et al.
BMJ Open|June 9, 2022
Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: a systematic review and network meta-analysis protocolJulia Lyons, Stephanie Campese, Yvonne C Learmonth, et al.
Multiple Sclerosis and Related Disorders|July 20, 2024
Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: A systematic reviewStephanie Campese, Julia Lyons, Yvonne C Learmonth, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 26, 2017
Infections in neuromyelitis optica spectrum disorderXiaonan Zhong, Yifan Zhou, Tingting Lu, et al.
Frontiers in Immunology|January 28, 2021
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple SclerosisStephanie Trend, Jonatan Leffler, Ingrid Teige, et al.
Multiple Sclerosis and Related Disorders|October 11, 2025
Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosisPrue H Hart, Christopher J Emig, Ahmed Z Obeidat, et al.
Pageof 12